Guiyang Xintian Pharmaceutical Co.,Ltd.
SHZ: 002873.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Da Lun Dong
- Employees
- 1,958
- Headquarters
- Guiyang, China
- IPO year
- 2017
- Market cap
- CN¥2.4B
- Website
- https://www.gyxtyy.com
Loading 002873…
Loading profile data…Frequently asked questions about 002873
What does Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ) do?
Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of Chinese medicines for various diseases in China. The company offers formulation products, which include hard capsules, gels, mixtures, granules, and tablets. Its products are used for the treatment of antitumor, gynecological, urinary, breast...
Where does 002873.SZ trade?
Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002873.SZ in?
Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Guiyang Xintian Pharmaceutical Co.,Ltd.?
Da Lun Dong is the chief executive officer of Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ).
Where is Guiyang Xintian Pharmaceutical Co.,Ltd. headquartered?
Guiyang Xintian Pharmaceutical Co.,Ltd. is headquartered in China.
Does 002873.SZ pay a dividend?
Yes — Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ) paid a trailing twelve-month dividend of CNY 0.06 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002873.SZ go public?
Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ) completed its initial public offering in 2017.